Sign in

CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943134940
Phone
4154825300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Director acquired 10,200 shares (grant or award)
  3. 4 Grant or award Director acquired 10,200 shares (grant or award)
  4. 4 Grant or award Director acquired 10,200 shares (grant or award)
  5. 4 Open-market sale Director sold 3,665 shares at $17.78 ($65,164)
  6. 4 Open-market sale Director sold 4,600 shares at $17.94 ($82,524)
  7. 4 Open-market sale Director sold 3,665 shares at $17.78 ($65,164)
  8. 4 Option exercise Director acquired 40,000 shares (option exercise)
  9. 4 Open-market sale Director sold 18,279 shares at an average $16.01 ($292,670)
  10. 4 Option exercise Director acquired 45,000 shares (option exercise)
  11. 4 Gift Director gave 6,300 shares (gift)
  12. 4 Open-market sale Chief R&D Officer sold 7,662 shares at $13.83 ($105,965)
  13. 4 Open-market sale SVP & General Counsel sold 1,910 shares at $13.83 ($26,415)
  14. 4 Open-market sale President & CEO sold 11,515 shares at $13.83 ($159,252)
  15. 4 Open-market sale SVP & Chief Accounting Officer sold 13,339 shares at $13.83 ($184,478)
  16. 4 Open-market sale SVP & Chief Commercial Officer sold 6,192 shares at $13.83 ($85,635)
  17. 4 Open-market sale SVP, COO & CFO sold 10,867 shares at an average $13.76 ($149,481)
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 21 of 100 · 1,982 filings